[HTML] oncm.org

[HTML][HTML] COX-2 inhibitors, a potential synergistic effect with antineoplastic drugs in lung cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - Oncomedicine, 2017 - oncm.org
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
被引用次数：4 相关文章
[PDF] archive.org

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - scholar.archive.org
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] academia.edu

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - academia.edu
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] auth.gr

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - ikee.lib.auth.gr
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] semanticscholar.org

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - pdfs.semanticscholar.org
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] researchgate.net

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - researchgate.net
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] oncm.org

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - oncm.org
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] academia.edu

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - academia.edu
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …
[PDF] researchgate.net

[PDF][PDF] COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, K Domvri, N Zogas… - researchgate.net
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …

COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer

W Hohenforst-Schmidt, P Zarogoulidis, S Petanidis… - Oncomedicine, 2017 - ikee.lib.auth.gr
Background: Lung cancer represents the leading cause of cancer-related deaths worldwide
and novel therapeutic approaches targeting crucial pathways are urgently needed to …